Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: avatrombopag maleate
Trade Name:
Date Designated: 09/01/2011
Orphan Designation: Treatment of idiopathic thrombocytopenic purpura
Orphan Designation Status: Designated/Approved
Sobi, Inc.
240 Leigh Farm Road
Suite 245
Durham, North Carolina 27707
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

Marketing approved:

1 Generic Name: avatrombopag maleate
Trade Name:
Marketing Approval Date: 06/26/2019
Approved Labeled Indication: DOPTELET is indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment
Exclusivity End Date: 06/26/2026 
Exclusivity Protected Indication* :  For the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment
*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-